Susquehanna International Group
TRAW icon

Susquehanna International Group’s Traws Pharma TRAW Stock Holding History

Susquehanna International Group’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-596
Closed -$38K – 14131
2021
Q4 		$38K Sell
596
-1,964
-77% -$158K ﹤0.01% 12679
2021
Q3 		$245K Buy
+2,560
New +$330K ﹤0.01% 11050
2015
Q3 		– Hold
0
– -$27K – 10299
2015
Q2 		– Hold
0
– – – 9966

Other funds holding TRAW

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PWM
Palumbo Wealth Management Great Neck, New York $410M AUM 32.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Susquehanna International Group's TRAW Position: Q1 2026 in Review

Susquehanna International Group sold out of Traws Pharma (TRAW) in Q1 2026, closing a stake of 14,197 shares — an estimated $16K sold.

Susquehanna International Group first reported a position in TRAW in Q2 2018 and held it in 10 quarters. The position peaked at $397K in Q1 2021. 28 funds tracked by Wall St. Rank hold TRAW as of Q1 2026.

  • Susquehanna International Group reported no remaining Traws Pharma position as of Q1 2026 after selling out during the quarter.
  • Susquehanna International Group sold 14,197 Traws Pharma shares in Q1 2026, an estimated $16K.
  • Susquehanna International Group first reported a position in Traws Pharma in Q2 2018 and held it in 10 quarters.
  • Susquehanna International Group's Traws Pharma position peaked at $397K in Q1 2021.
  • 28 funds tracked by Wall St. Rank held Traws Pharma as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.